IPSEN (IPN.PA) Financials
IPN.PA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 6.3 billion | 2.5 billion |
| 2023-06-30 | 6.1 billion | 2.7 billion |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 5.6 billion | 2.3 billion |
IPN.PA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 318.7 million | ? |
| 2023-06-30 | 470.0 million | 17.5 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 600.0 million | 14.0 million |
IPN.PA Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 421.9 million |
| 2023-06-30 | 195.1 million |
| 2023-03-31 | ? |
| 2022-12-31 | 209.9 million |
IPN.PA Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 528.4 million | - | - |
| 2023-06-30 | 438.1 million | 351.9 million | - |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 1.2 billion | 667.0 million | 109.7 million |
IPN.PA Shares Outstanding
IPN.PA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 109.9 million | 329.1 million | - | - |
| 2023-06-30 | 40.6 million | 290.2 million | 108.4 million | 444.3 million |
| 2023-03-31 | - | - | - | - |
| 2022-12-31 | 48.4 million | 238.1 million | 110.4 million | 441.5 million |
IPN.PA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.6 billion | 301.3 million |
| 2023-06-30 | 1.6 billion | 269.9 million |
| 2023-03-31 | - | - |
| 2022-12-31 | 1.7 billion | 285.6 million |
IPN.PA
Price: €120.80
Dividend Yield: 0.01%
Forward Dividend Yield: 0.99%
Payout Ratio: 16.22%
Dividend Per Share: 1.20 EUR
Earnings Per Share: 7.41 EUR
P/E Ratio: 21.04
Exchange: PAR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 10.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 19